IGF-1 LR3 in humans There are no published Phase 2 or Phase 3 human RCTs evaluating IGF-1 LR3 for body composition, fat loss, or muscle accretion in healthy or metabolically compromised adults
Contact us today for more information, or simply schedule an appointment online
Current evidence remains exploratory, with no approved human applications, positioning the neurological research surrounding BPC-157 and neural repair as preliminary but consistently documented across animal models
Everything else waits
Protein and fiber intake, hydration, and workout consistency were my daily go-dos
NAD+ and 5-Amino-1MQ Synergy: Protecting NAD+ While Boosting Mitochondrial Function When paired with 5-Amino-1MQ, longevity experts discovered NAD+ therapy worked better and lasted longer, marking a potential breakthrough in how we approach slowing age-related cellular decline, especially for adults over 40